Clinton Musil

Director of Finance/CFO at

Skyhawk Therapeutics, Inc.

45 year

85 connections

Finance

Health Technology

Consumer Services

Profile

Clinton Musil currently works at Skyhawk Therapeutics, Inc., as President & Chief Financial Officer.
Mr. Musil also formerly worked at Wells Fargo & Co., as Vice President-Healthcare Investment Banking Group from 2013 to 2014, Deutsche Bank AG, as Vice President-Healthcare Investment Banking Group from 2014 to 2017, Personalis, Inc., as Chief Business Officer, Needham & Co. LLC, as Principal, Essex Woodlands Management, Inc., as Vice President, ARMO BioSciences, Inc., as Vice President-Corporate Development from 2017 to 2018, Catalyst Biosciences, Inc., as Chief Financial Officer from 2020 to 2021, and Skyhawk Therapeutics, Inc., as Chief Financial Officer from 2021 to 2024.
Mr. Musil received his undergraduate degree from the University of Arizona and Masters Business Admin degree from Harvard Business School.

Clinton Musil active positions

Companies	Position	Start
Skyhawk Therapeutics, Inc. Skyhawk Therapeutics, Inc. BiotechnologyHealth Technology Develops novel RNA-targeting small molecule for neurology, oncology and fibrotic diseases	Director of Finance/CFO	30/11/2024

All active positions of Clinton Musil

Former positions of Clinton Musil

Companies	Position	End
Skyhawk Therapeutics, Inc. Skyhawk Therapeutics, Inc. BiotechnologyHealth Technology Develops novel RNA-targeting small molecule for neurology, oncology and fibrotic diseases	Director of Finance/CFO	01/02/2024
CATALYST BIOSCIENCES	Director of Finance/CFO	29/10/2021
ARMO BIOSCIENCES INC	Corporate Officer/Principal	01/07/2018
DEUTSCHE BANK AG	Corporate Officer/Principal	01/03/2017
WELLS FARGO & COMPANY	Corporate Officer/Principal	01/07/2014

See the detail of Clinton Musil's experience

Training of Clinton Musil

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Clinton Musil's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	10
Wells Fargo & Co. Wells Fargo & Co. Major BanksFinance Operates as a bank holding company whose subsidiaries provides consumer, commercial, corporate, investment banking and wealth management services	Finance
Deutsche Bank AG Deutsche Bank AG Investment Banks/BrokersFinance Provides investment and corporate banking & asset management services	Finance
Personalis, Inc. Personalis, Inc. Medical/Nursing ServicesHealth Services Operates as a cancer genomics company which transforms the development of next-generation therapies	Health Services
Needham & Co. LLC Needham & Co. LLC Investment Banks/BrokersFinance Provides brokerage services	Finance
University of Arizona University of Arizona Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Essex Woodlands Management, Inc. Essex Woodlands Management, Inc. Investment ManagersFinance EW Healthcare Partners invests in public and private companies located in the North America, Latin America, Asia, and Europe with revenues ranges from USD 20 - 200 million. The firm focuses on sectors such as pharmaceutical, medical device, healthcare services, and healthcare IT. The firm participates in growth capital requirements with an investment size range from USD 20 - 100 million. It takes minority or majority interest and requires a board position.	Finance
Harvard Business School Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
ARMO BioSciences, Inc. ARMO BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Develops immunotherapy for treatment of cancer	Health Technology
Catalyst Biosciences, Inc. Catalyst Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company	Health Technology
Skyhawk Therapeutics, Inc. Skyhawk Therapeutics, Inc. BiotechnologyHealth Technology Develops novel RNA-targeting small molecule for neurology, oncology and fibrotic diseases	Health Technology